All articles tagged with #ai in healthcare
Edward Patrick, an NHS anaesthetist in Oxfordshire, used an AI chatbot to identify a vitamin B6 deficiency causing his mother Ann's life-threatening seizures. After months of undiagnosed symptoms and a near-fatal episode of rhabdomyolysis, the AI analysis led to immediate treatment that stopped the seizures and saved her life.
KFF Health News reports that the Trump administration established a private Slack workspace to coordinate AI health policy with major tech firms, bypassing public oversight. This 'Health Technology Ecosystem' allowed companies like Microsoft and Google to influence the Medicare App Library and reimbursement rules without public notice, raising concerns about regulatory capture and patient data privacy.
Artificial intelligence is reshaping dermatology services in the UK by accelerating skin cancer detection and reducing unnecessary procedures. At St Luke's Hospital in Bradford, the DERM system has increased patient throughput by one-third and cut unnecessary biopsies by 10%. A broader study presented in Vienna suggests autonomous AI could free up specialist time for over 8,500 additional appointments across two hospitals, addressing severe workforce shortages in dermatology.
An NHS anaesthetist used Google's Gemini AI to identify a rare vitamin B6 deficiency in his mother, a Parkinson's patient suffering from continuous seizures. This discovery led to an intravenous supplement that stopped the seizures and restored her cognitive function. While the case highlights AI's potential in clinical settings, experts urge caution and emphasize the need for formal trials to validate the link between B6 deficiency and Parkinson's medications.
Artificial intelligence is increasingly used in cancer care, but its impact varies from promising detection tools to curated clinical decision support. While big tech promises cures, practical applications focus on managing information overload, with tools like Onqo Health's Easy Oncology gaining traction among oncologists. AI excels in pattern recognition but faces risks of bias and overreliance, necessitating human oversight.
A controversial JAMA paper by bioethicist Ezekiel Emanuel and venture capitalist Vinod Khosla argues that AI will soon surpass human physicians in cognitive medical tasks, potentially making human-AI hybrid care less effective than AI alone. The American Medical Association (AMA) CEO John Whyte strongly disputes this, citing methodological flaws and patient communication issues. While AI adoption is accelerating, with 60% of US doctors using clinical AI tools, experts warn that human oversight remains critical for now. Concurrently, major AI firms like Anthropic are pivoting toward healthcare to improve public perception and secure funding, though breakthroughs in drug discovery remain years away.
A new AI tool from Imperial College London can detect heart disease from ECGs in seconds, while France introduces fees on ultra-fast fashion to curb environmental impact. Meanwhile, China’s solar capacity has surpassed coal, and Timor-Leste has eliminated trachoma as a public health threat.
Major AI companies are aggressively entering the healthcare sector to mitigate public opposition and support upcoming initial public offerings. While AI tools are already streamlining clinical workflows and drug discovery, experts warn that significant medical breakthroughs remain years away. This strategic pivot aims to reframe AI as a public good, though it faces hurdles from regulatory uncertainty, high costs, and ethical concerns regarding data privacy and potential misuse.
Hims & Hers CEO Andrew Dudum defends the company against an FTC lawsuit over data sharing and subscription practices, arguing the digital model increases access. He notes past price reductions from selling compounded GLP-1s, says Novo Nordisk dropped a patent suit and the firm now sells Novo’s branded drugs, and signals a move toward in-house AI to lower costs and transform healthcare.
AI is increasingly used in medicine, but patient trust remains mixed; experts say AI should aid rather than replace clinicians - human in the loop - and patients should ask four questions (will AI be used, how is data protected, can I opt out, how is AI being tested) and disclose any AI tools used to keep decision-making open and transparent.
OpenAI is rolling ChatGPT Health out to all US users, letting people connect medical records and health data to the main chat. The company claims its health models can reason at clinician-level levels, but officials urge tempered language as evidence is mixed. Health conversations are encrypted in transit and at rest, with users controlling what data is connected, and the rollout spans free, Go, Plus, and Pro plans, following the GPT-5.6 Sol health push amid a related lawsuit over dangerous medical recommendations.
STAT reports a leadership exodus at Epic, highlighted by Sumit Rana’s departure and other executive exits, fueling questions about the company’s direction amid health-tech talent churn; the issue also covers LifeMD’s GLP-1 telehealth controversy, Nabla naming a new CEO as AI competition intensifies, notable hires across Aledade and TytoCare, and a broader health-tech funding and policy roundup.
Mayo Clinic is rapidly integrating AI into care, with about 150 AI models in use and a record-summarizing tool called Record Time that helps clinicians prepare for patient visits more efficiently. The hospital collaborates with Microsoft and Scale AI to develop healthcare-focused AI and is running clinical pilots (including early pancreatic cancer detection and atrial fibrillation risk analysis) to test accuracy and safety. Mayo emphasizes rigorous validation, clinician involvement, and privacy safeguards, while noting AI will change job roles rather than replace staff, with adoption hinging on trust and practical usefulness.
Small language models (SLMs) offer a scalable, practical alternative to large language models for medical tasks, enabling broader real-world deployment across diverse clinical settings, but they trade off some accuracy and robustness and require careful evaluation, domain adaptation, and governance to address safety and integration challenges.
East Kent Hospitals NHS Trust is deploying MEMORI, an AI tool from Sanome, to analyze routine patient data (blood tests, vitals, medications, and demographics) and generate an infection risk score, enabling clinicians to spot hospital-acquired infections early and act sooner, while staff remain central to care; the system is designed to support clinicians, improve care and bed flow, and is part of the NHS's digital healthcare push.